Specialized Radiation Therapy Solutions for Niche Environments

Publication ID: 24-11857803_0004_PTD
Published: October 28, 2025
Category:Specialized Variations & Niche Solutions

Legal Citation

pr1or.art Inc., “Specialized Radiation Therapy Solutions for Niche Environments,” Published Technical Disclosure No. 24-11857803_0004_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857803_0004_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,803.

Summary of the Inventive Concept

Adapting alpha-emitter radiation therapy for high-security needs, disaster relief, extreme weather conditions, remote areas, and search and rescue operations.

Background and Problem Solved

The original patent disclosed a novel approach to diffusing alpha-emitter radiation therapy with enhanced beta treatment. However, the patent's design and implementation were not tailored to specific, narrow markets or unique operational environments. This inventive concept addresses the need for specialized radiation therapy solutions that cater to these niche requirements.

Detailed Description of the Inventive Concept

The inventive concept comprises a range of specialized radiation therapy solutions, each designed to address the unique challenges of a specific niche environment. For high-security facilities, the radiation source is encased in a secure enclosure to prevent unauthorized access. For disaster relief, a portable radiation source is deployed to the disaster area, allowing for rapid administration of radiation therapy to affected individuals. In extreme weather conditions, the radiation source is housed in a waterproof and shock-resistant enclosure to ensure continued operation. For remote areas, a satellite-based radiation source is employed, complete with a communication system for remote monitoring and control. Lastly, for search and rescue operations, a compact and lightweight radiation source is designed with a high concentration of alpha emitting atoms.

Novelty and Inventive Step

The new claims introduce novel and non-obvious adaptations of the original patent's concept to specific niche environments, providing a unique value proposition for each targeted market. The inventive step lies in the integration of the original patent's alpha-emitter radiation therapy with the specialized requirements of each niche environment.

Alternative Embodiments and Variations

Alternative embodiments could include modifying the radiation source's design for use in other niche environments, such as space exploration or high-altitude operations. Variations could also involve using different types of radiation or alternative materials for the radiation source's construction.

Potential Commercial Applications and Market

The inventive concept has significant commercial potential in various industries, including healthcare, disaster relief, and search and rescue operations. The targeted markets include high-security facilities, remote areas, and disaster relief organizations, offering a unique solution for each niche environment.

Field of Art

Medical radiation therapy, specifically interstitial radiation sources for targeted tumor treatment, requiring expertise in radioisotope engineering, medical device design, and radiation physics

Person of Ordinary Skill (PHOSITA) Profile

A medical physicist or biomedical engineer with advanced degrees, experience in radiation therapy device design, understanding of radiation source fabrication, and knowledge of environmental adaptation strategies for medical technologies

Obviousness Rationale

A PHOSITA would recognize that the fundamental alpha-emitter radiation therapy concept can be readily adapted to different environmental contexts by applying standard engineering design principles. The core radiation source technology remains consistent, with modifications primarily addressing deployment, protection, and operational constraints. These variations represent predictable extensions of the source patent's core radiation therapy innovation.

Obvious Combinations & Variations

Source Patent Element
Alpha emitting atoms attached to a base with specific concentration levels (6-12 μCi per centimeter)
PTD Variation
Increasing alpha emitting atom concentration to 15 μCi per centimeter for search and rescue compact radiation sources
Obviousness Reasoning
Incremental concentration adjustments are a routine design optimization that a PHOSITA would find obvious, especially when targeting compact, high-performance medical devices
Source Patent Element
Base suitable for implanting in a tumor with alpha emitting atoms
PTD Variation
Adding secure enclosures, waterproof housings, and environmental adaptations for specific deployment scenarios
Obviousness Reasoning
Protecting medical radiation sources from environmental factors is a standard engineering practice, representing a predictable solution to operational challenges
Source Patent Element
Radiation source with combined alpha and non-alpha radiation
PTD Variation
Integrating remote monitoring and satellite-based communication systems for radiation source control
Obviousness Reasoning
Implementing telemetry and remote management for medical devices is a known technique in medical technology, representing an obvious technological extension
Source Patent Element
Interstitial radiation source design for tumor treatment
PTD Variation
Adapting radiation sources for disaster relief, high-security, and search and rescue applications
Obviousness Reasoning
Repurposing medical technologies for alternative critical environments is a standard innovation approach that a PHOSITA would find straightforward and predictable
Source Patent Element
Base with alpha emitting atoms like radium-224
PTD Variation
Exploring alternative radiation source materials and configurations for space exploration or high-altitude operations
Obviousness Reasoning
Investigating material and design variations for extreme environments is a routine engineering approach with predictable problem-solving methodologies
35 U.S.C. § 103 Summary: Based on US Patent 11857803's disclosure of interstitial radiation sources, the present publication demonstrates that a Person Having Ordinary Skill In The Art would find the claimed variations obvious through routine engineering adaptations. The disclosed environmental modifications, concentration adjustments, and deployment strategies represent predictable extensions of the source patent's core radiation therapy technology, thereby establishing prima facie obviousness under 35 U.S.C. § 103.

Original Patent Information

Patent NumberUS 11,857,803
TitleDiffusing alpha-emitter radiation therapy with enhanced beta treatment
Assignee(s)Alpha Tau Medical Ltd